News Results
There are 1,055,247 News Results
May 16, 2024
Empowering HVAC and Plumbing Contractors with Enhanced Warranty Management Tools ARGYLE, Texas, May 16, 2024 /PRNewswire-PRWeb/ -- JB Warranties, the leading provider of warranty solutions in the HVAC and plumbing...
Feb 28, 2024
MOLINE, Ill., Feb. 28, 2024 /PRNewswire/ -- The Deere & Company (NYSE: DE) Board of Directors today declared a quarterly dividend of $1.47 per share payable May 8, 2024, to...
Mar 1, 2024
STOCKHOLM, March 1, 2024 /PRNewswire/ -- Loomis AB has through the repurchase program that was resolved and communicated on January 30, 2024, and that is still being executed, repurchased 310,898...
Mar 1, 2024
WALTHAM, Mass., March 1, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on March 1, 2024 the...
Mar 8, 2024
MOUNT GILEAD, N.C., March 8, 2024 /PRNewswire/ -- McRae Industries, Inc. (Pink Sheets: MCRAA and MCRAB) declared a dividend of $.14 per share on the Company's Class A and Class...
Mar 21, 2024
WOONSOCKET, R.I., March 21, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents)...
Apr 5, 2024
WALTHAM, Mass., April 5, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on April 1, 2024 the...
Apr 5, 2024
WALTHAM, Mass., April 5, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on April 1, 2024 the...
Apr 26, 2024
NEW BRITAIN, Conn., April 26, 2024 /PRNewswire/ -- Stanley Black & Decker (NYSE: SWK), a worldwide leader in Tools and Outdoor, announced today that its Board of Directors approved a...
May 3, 2024
WALTHAM, Mass., May 3, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on May 1, 2024 the...
